ResMed
(ASX) RMD
ResMed Financials at a Glance
Market Cap
A$40.21B
Revenue (TTM)
$5.55B
Net Income (TTM)
$1.52B
EPS (TTM)
A$1.57
P/E Ratio
17.68
Dividend
A$0.35
Beta (Volatility)
0.01 (Low)
Dividend
A$0.35
Beta (Volatility)
0.01 (Low)
Price
A$27.72
Volume
2,469,407
Open
A$27.50
Price
A$27.72
Volume
2,469,407
Open
A$27.50
Previous Close
A$27.72
Daily Range
A$27.27 - A$27.75
52-Week Range
A$25.50 - A$45.25
Estimated Earnings Date
Jul 30, 2026
Dividend
A$0.35
Beta (Volatility)
0.01 (Low)
Price
A$27.72
Volume
2,469,407
Open
A$27.50
Previous Close
A$27.72
Daily Range
A$27.27 - A$27.75
52-Week Range
A$25.50 - A$45.25
Estimated Earnings Date
Jul 30, 2026
RMD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ResMed
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
10,600
CEO
Mick Farrell, MBA
Website
www.resmed.comHeadquarters
San Diego, CA 92123, US
RMD Financials
Key Financial Metrics (TTM)
Gross Margin
62%
Operating Margin
34%
Net Income Margin
27%
Return on Equity
25%
Return on Capital
26%
Return on Assets
17%
Earnings Yield
5.66%
Dividend Yield
1.27%
Payout Ratio
22.39%
Stock Overview
Market Cap
A$40.21B
Shares Outstanding
1.45B
Volume
2.47M
Avg. Volume
1.47M
Financials (TTM)
Gross Profit
$3.05B
Operating Income
$1.69B
EBITDA
$1.92B
Operating Cash Flow
$1.75B
Capital Expenditure
-$100.64M
Free Cash Flow
$1.65B
Cash & ST Invst.
$1.21B
Total Debt
$851.81M
ResMed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.42B
+9.8%
Gross Profit
$871.71M
+13.7%
Gross Margin
61.46%
N/A
Market Cap
A$40.21B
N/A
Market Cap/Employee
A$4.03M
N/A
Employees
9,980
N/A
Net Income
$395.10M
+8.2%
EBITDA
$569.46M
+19.1%
Quarterly Fundamentals
Total Cash
$1.67B
+79.0%
Total Debt
$847.66M
+0.9%
Accounts Receivable
$1.00B
+10.6%
Inventory
$916.74M
+6.3%
Long Term Debt
$556.96M
-30.5%
Short Term Debt
$290.70M
+652.0%
Return on Assets
17.30%
N/A
Return on Invested Capital
25.54%
N/A
Free Cash Flow
$523.25M
-5.7%
Operating Cash Flow
$556.59M
-3.8%